-
Pharma Contract Services Consolidation Wave Continues
Many CDMOs are expanding their breadth of capabilities and entering new geographic markets through the acquisition of other service providers.
PAP-Q3-17-NO-001 -
Evolving Role of the Process Architect
Evolution in the life sciences industry is driving the need for new manufacturing paradigms based on advanced technologies.
PAP-Q3-17-CL-008 -
Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines
Supply Chain Logistics Providers must be experienced with all relevant customs regulations and the specialized requirements for shipping sensitive materials.
PAP-Q3-17-CL-007 -
Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
PAP-Q3-17-DL-001 -
Mergers & Acquisitions: Combining Market Segments
Nice Insight is in conversation with Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director at The Dow Chemical Company
PAP-Q3-17-IC-001 -
Building the Foundation of Japan’s Premier CDMO
To meet global markets head-on, Bushu and Spera have built a capable proactive organization, that is well positioned in Japan to serve the region.
PAP-Q3-17-CL-006 -
Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing
Transient transfection for vector production offers significant flexibility for cell and gene therapy development.
PAP-Q3-17-CL-005 -
Russian Pharma Market Offers Great Potential for Local Manufacturers
The Russian market presents new growth opportunities for pharmaceutical companies with manufacturing capabilities within the country.
PAP-Q3-17-CL-004 -
Achieving a High Level of Customer Service Through Lean Quality Management
Providing customers with their order when they want it, at the right price and quantity, is only laying the foundation for excellent customer service.
PAP-Q3-17-CL-001 -
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
The pharmaceutical industry, in conjunction with FDA, has focused on identifying approaches for the development of abuse-deterrent opioid formulations
PAP-Q3-17-CL-003 -
Oral Solid Dose Manufacturing Efficiency is Driving New Attention to Plant Design
As OSD formulations have grown more sophisticated, technologies to match these advances have been developed for the manufacture of these novel delivery systems.
PAP-Q3-17-CL-002 -
Combining Content and Research in a Single Website Platform
Pharma’s Almanac has integrated with Nice Insight.
PAP-Q3-17-NI-001 -
The Road to BIO in Review
A once-in-a-lifetime journey from Boston to San Diego inspires and garners a deeper understanding of the people who have fueled it all
PAP-Q3-17-RB-001 -
New Manufacturing Paradigms in an Evolving Pharma Industry: Partnering in the Equipment Space Across Channels
Like the pharmaceutical industry, relationships between pharmaceutical engineering/design firms and equipment suppliers are constantly in flux.
PAP-Q3-17-FA-003 -
Building Strategic Sponsor-CRO Partnerships: The International Element Changing Clinical Trials
The global CRO market is expanding and increasingly borderless.
PAP-Q3-17-FA-002 -
The CDMO and the International Supply Chain: How Global and Local Relationships Are Guiding Sponsors and Providers
A well-thought-out and structured partnership can bring a sponsor organization both strength and agility.
PAP-Q3-17-FA-001 -
Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?
Experts weigh in on our Roundtable question.
PAP-Q3-17-RT-001
-
Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines
Wes Wheeler, CEO, and Ariette van Strien, Chief Commercial Officer for Marken explain the company’s personalized supply chain solutions for clinical trial materials and sensitive drug shipments worldwide.
-
Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing
Richard Snyder, Ph.D., Chief Scientific Officer, Scott Jeffers, Ph.D., Associate Director of Technical Operations and Ying Cai, Ph.D., Associate Director of Manufacturing Sciences at Brammer Bio discuss transient transfection for vector production.
-
Catalent Acquires Cook Pharmica
The company gains sterile fill/finish operations to meet the rising demand for biologics.
-
Russian Pharma Market Offers Great Potential for Local Manufacturers
Renaud Bessière, Plant Manager, Servier Russia, explains the nation's market.
-
FDA Approves First Biosimilar Treatment for Multiple Cancers
Amgen’s Mvasi biosimilar is approved.
-
Alliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology
GSK, AstraZeneca and Labcyte collaborate to combine acoustic liquid dispensing with mass spectrometry to reduce costs and cycle times.
-
M+W Group on the Road to BIO: Ensuring Your Project’s Success
Peter Cramer, AIA, NCARB, Vice President, Life Science Facility Design at M+W Group discusses the role of the process architect.
-
Potential Breakthrough HIV/AIDS Intervention Developed
Sanofi study demonstrates genetically engineered antibodies can target multiple sites in one molecule.
-
Ajinomoto Althea Set to Open New Capacity in San Diego
A new GMP production suite at the High Potency Products (HPP) facility is in the works.
-
What New Technology Introduced Within the Last Year Have You Found to Have the Most Impact on Your Business?
Experts weigh in on our industry roundtable.
-
Building the Foundation of Japan’s Premier CDMO
Jun Yokohama, President & CEO of Bushu Pharmaceuticals Ltd. and Toshio Yoshioka, President at Spera Pharma, Inc. discuss how the firm helps clients overcome barriers to entry.
-
Mitigating Shortages of Injectable Drugs in the United States
Marga Viñes, Business Development Manager at Grifols explains how to tackle drug shortages.
-
Mergers & Acquisitions: Combining Market Segments
Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director at The Dow Chemical Company, discuss the drivers behind the merger.
-
Chinese Biopharmaceutical Company Acquires a Canada-Based CDMO
3SBio, as part of a joint venture formed with CPE Funds, has acquired Canadian biologics CDMO Therapure Biopharma.
-
New CDMO/CRO Collaboration Announced
ReciPharm and Clinical Trial Consultants are launching a new service to facilitate first-in-human trials.
-
Innovation and Partnership Through Experience and Acquisition
Avara CEO Tim Tyson explains the company’s acquisition strategy.
-
Moving Quality to the Forefront Brings Measurable Results
Chris Curtin, Executive Vice President and Chief Operating Officer of UPM Pharmaceuticals explains the implementation of Manufacturing Quality Assurance (MQA).
-
GSK Shingles Vaccine Recommended for Approval by FDA Panel
Shingrix would be the only other treatment for shingles approved in the US.
-
Focusing on Clinical and Research Services
Julia Sardayan, Director of Corporate Development at Smooth Drug Development explains plans for the company going forward.
-
New Organ-On-A-Chip Designed to Model Influenza Virus Infections
Researchers will use the technology to identify new drug targets and therapies.
MOST VIEWED THIS MONTH
The Road To BIO: An Epic Journey
View All
Pharma's Almanac TV
View All VideoAttracting Investors and Shortening Development Times
James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
Providing a Complete Modular Solution
George Wiker, Executive Director, AES
Bringing Bioscience to Space
Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics
Harmonizing Development Internationally
Trishul Shah, Associate Director of Business Development, Polypeptide Group
Latest
View All LatestAlliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology
Sep 26, 2017 1:00:34 PM PAO-M09-17-NI-031FDA Approves First Biosimilar Treatment for Multiple Cancers
Sep 26, 2017 12:57:45 PM PAO-M09-17-NI-030GSK Shingles Vaccine Recommended for Approval by FDA Panel
Sep 21, 2017 2:50:43 PM PAO-M09-17-NI-027New Organ-On-A-Chip Designed to Model Influenza Virus Infections
Sep 21, 2017 2:05:50 PM PAO-M09-17-NI-025Chinese Biopharmaceutical Company Acquires a Canada-Based CDMO
Sep 21, 2017 2:00:55 PM PAO-M09-17-NI-024Mitigating Shortages of Injectable Drugs in the United States
Sep 20, 2017 4:47:40 PM PAO-M09-17-Cl-001Findings Suggest Low-Cal Sweeteners Pose No Increased Diabetes Risk
Sep 19, 2017 2:30:15 PM PAO-M09-17-NI-023GSK and Innoviva Present Positive Results from Pioneering Asthma Study
Sep 19, 2017 12:46:59 PM PAO-M09-17-NI-020Baxter Expands Generic Injectables Portfolio with Claris Injectables Acquisition
Sep 15, 2017 2:07:16 PM PAO-M09-17-NI-018Perfusion Appears to be Gaining Traction in Biopharma Manufacturing
Sep 14, 2017 4:31:28 PM POP-M08-17-NI-001Press Releases
View All PRTOPICS
View All Topics
Columns
Systems Integrators and Technologists: Evolving Role of the Process Architect
